NCT00710086View on ClinicalTrials.gov

Intravenous Remifentanil for Labor Analgesia

PHASE4CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Labor Pain
Interventions
DRUG

Hydromorphone

Intravenous administration of hydromorphone 1mg at the patient's request if they felt uterine contraction pain

DRUG

Remifentanil

Remifentanil intravenous PCA: 0.2μg/kg, lockout time interval 2 minutes, continuous infusion rate 0.2-0.8μg/kg/min.

Trial Locations (1)

210004

Nanjing Maternal and Child Health Care Hospital, Nanjing

Sponsors
All Listed Sponsors
collaborator

HRSA/Maternal and Child Health Bureau

FED

lead

Nanjing Medical University

OTHER